262 related articles for article (PubMed ID: 2467947)
1. [Biological markers and germinal tumors of the testis. Value and limitations of the assay of chorionic gonadotrophin hormone and alpha-fetoprotein].
Bassoulet J; Pabot du Chatelard P; Ricordel I; Auberget JL; Guillemot MC; Merrer J; Timbal Y
J Urol (Paris); 1988; 94(8):393-6. PubMed ID: 2467947
[TBL] [Abstract][Full Text] [Related]
2. Serum alpha-fetoprotein and human chorionic gonadotropin in the management of testicular tumors.
Lange PH
Natl Cancer Inst Monogr; 1978 Dec; (49):215-7. PubMed ID: 86163
[TBL] [Abstract][Full Text] [Related]
3. Immunochemical determination of human chorionic gonadotropin and alpha-fetoprotein in sera and tumors of patients with testicular cancer.
Javadpour N; McIntire KR; Waldmann TA
Natl Cancer Inst Monogr; 1978 Dec; (49):209-13. PubMed ID: 86162
[TBL] [Abstract][Full Text] [Related]
4. Tumor markers in patients with non-seminomatous germ cell tumors of the testis.
Willemse PH; Sleijfer DT; Schraffordt Koops H; De Bruijn HW; Oosterhuis JW; Brouwers TM; Ockhuizen T; Marrink J
Oncodev Biol Med; 1981; 2(1-2):117-28. PubMed ID: 6170952
[TBL] [Abstract][Full Text] [Related]
5. Applications of biologic tumor markers in testicular cancer.
Javadpour N
Cancer Treat Rep; 1979; 63(9-10):1643-7. PubMed ID: 91433
[TBL] [Abstract][Full Text] [Related]
6. The management of patients with clinical stage I nonseminomatous testicular tumors and persistently elevated serologic markers.
Saxman SB; Nichols CR; Foster RS; Messemer JE; Donohue JP; Einhorn LH
J Urol; 1996 Feb; 155(2):587-9. PubMed ID: 8558665
[TBL] [Abstract][Full Text] [Related]
7. Use of serum beta-chain human chorionic gonadotropin in the management of testis tumor.
Walter MC
Natl Cancer Inst Monogr; 1978 Dec; (49):219. PubMed ID: 748772
[TBL] [Abstract][Full Text] [Related]
8. Human chorionic gonadotropin-positive seminoma: is this a special type of seminoma with a poor prognosis?
Scheiber K; Mikuz G; Frommhold H; Bartsch G
Prog Clin Biol Res; 1985; 203():97-104. PubMed ID: 3832120
[TBL] [Abstract][Full Text] [Related]
9. [Biological markers for tumours of the testis. Their use in diagnosis, prognosis and follow-up in 200 cases (author's transl)].
Bellet D; Caillaud JM; Droz JP; Delarue JC; Bohuon C
Nouv Presse Med; 1981 Nov; 10(40):3293-7. PubMed ID: 6170931
[TBL] [Abstract][Full Text] [Related]
10. Serum alpha fetoprotein and human chorionic gonadotropin in the diagnosis and management of nonseminomatous germ-cell testicular cancer.
Lange PH; McIntire KR; Waldmann TA; Hakala TR; Fraley EE
N Engl J Med; 1976 Nov; 295(22):1237-40. PubMed ID: 62281
[No Abstract] [Full Text] [Related]
11. [Tumor marker in urology].
Shimazaki J; Ito H; Miyauchi T; Maruoka M; Isaka S; Masukagami T; Ando K
Gan No Rinsho; 1983 May; 29(6):684-92. PubMed ID: 6192269
[TBL] [Abstract][Full Text] [Related]
12. [Beta-HCG positive seminoma--incidence with special reference to tumor marker concentration in testicular venous blood].
Mumperow E; Kressel K; Hartmann M
Urologe A; 1991 Mar; 30(2):114-6; discussion 117. PubMed ID: 1711727
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous measurement of tumor cytosol and peripheral serum levels of human chorionic gonadotropin and alphafetoprotein in testicular cancer.
Javadpour N; Woltering E; Soares T
Invest Urol; 1980 Jul; 18(1):11-2. PubMed ID: 6157650
[TBL] [Abstract][Full Text] [Related]
14. [Tumor marker diagnosis in non-seminomatous testicular tumors using human chorionic gonadotropin (HCG) and alpha fetoprotein (AFP)].
Boewer C; Nawka S; Fleck H; Uibel M; Immer U; Schmidt HE; Herzmann H; Pilgrim G; Ziegenbein R
Z Urol Nephrol; 1985 Feb; 78(2):77-86. PubMed ID: 2581393
[TBL] [Abstract][Full Text] [Related]
15. The value of tumor markers in testicular seminomas. Results of a prospective multicenter study.
Weissbach L; Bussar-Maatz R; Mann K
Eur Urol; 1997; 32(1):16-22. PubMed ID: 9266226
[TBL] [Abstract][Full Text] [Related]
16. [Assay of chorionic gonadotrophin, follicle-stimulating hormone and alpha-fetoprotein in the efferent blood in germinal tumors of the testis].
Henry R; Wiriot G; Longeon A; Timbal Y; Degrelle H
Presse Med; 1986 Jun; 15(26):1223-6. PubMed ID: 2428029
[TBL] [Abstract][Full Text] [Related]
17. [Significance of serum ferritin level in testicular tumors].
Takai K; Kojima H; Kume H; Takemura T; Moriyama N; Murahashi I; Aso Y
Hinyokika Kiyo; 1991 Apr; 37(4):357-62. PubMed ID: 1716405
[TBL] [Abstract][Full Text] [Related]
18. Human chorionic gonadotropin (HCG) and alpha-fetoprotein (AFP) in sera and tumor cells of patients with testicular seminoma: a prospective study.
Javadpour N; McIntire KR; Waldmann TA
Cancer; 1978 Dec; 42(6):2768-72. PubMed ID: 83187
[TBL] [Abstract][Full Text] [Related]
19. Factors that influence the results of salvage surgery in patients with chemorefractory germ cell carcinomas with elevated tumor markers.
Habuchi T; Kamoto T; Hara I; Kawai K; Nakao M; Nonomura N; Kobayashi T; Ogawa O; Kamidono S; Akaza H; Okuyama A; Kato T; Miki T
Cancer; 2003 Oct; 98(8):1635-42. PubMed ID: 14534879
[TBL] [Abstract][Full Text] [Related]
20. Predictive value of modeled AUC(AFP-hCG), a dynamic kinetic parameter characterizing serum tumor marker decline in patients with nonseminomatous germ cell tumor.
You B; Fronton L; Boyle H; Droz JP; Girard P; Tranchand B; Ribba B; Tod M; Chabaud S; Coquelin H; Fléchon A
Urology; 2010 Aug; 76(2):423-9.e2. PubMed ID: 20472276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]